Evidence map›Paper›PMID 39512404›Full record

ArticleAdvanced biomedical research2024

Evaluation of

Negar Dinarvand, Reza Azizi, Sedighe Rastaghi, Farzaneh Karimi, Abdolkarim Sheikhi, Morteza Pourfarzam

Abstract read
In one paragraph

Article in Advanced biomedical research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Negar DinarvandHyperlipidemia Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
Reza AziziDepartment of Basic and Laboratory Sciences, Khomein University of Medical Sciences, Khomein, Iran.
Sedighe RastaghiDepartment of Biostatistics, School of Public Health, Mashhad University of Medical Sciences, Mashhad, Iran.
Farzaneh KarimiDepartment of Physiology, Behbahan Faculty of Medical Sciences, Behbahan, Iran.
Abdolkarim SheikhiDepartment of Immunology, School of Medicine, Dezful University of Medical Sciences, Dezful, Iran.
Morteza PourfarzamDepartment of Clinical Biochemistry, School of Pharmacy and Pharmaceutical Sciences, Isfahan University of Medical Sciences, Isfahan, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Disturbances in lipid metabolism are one of the hallmarks of cancer cells. Fatty acid synthesis and oxidation play a crucial role in the proliferation, growth, and survival of cancer cells. Several enzymes are involved in lipid metabolism. MYC is an oncogene and plays various regulatory roles in lipid metabolism. This study aimed to evaluate Materials and Methods: Fifty-five pairs of samples of BC and noncancerous adjacent tissues were utilized in the present study to analyze Results: Conclusions: Although further research is required to assess MYC's impact on tumor metabolic regulation, the correlations seen here between

Indexed as

ACSL4breast cancerLipin-1MYC

Identifiers

PMID39512404
PMCPMC11542691

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.